SCHEMBL6808467

SCHEMBL6808467

CCCCCC[C@H](CC(=O)OC(C)(C)C)C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIK1 P39086 2/20 0.50
GRIK2 Q13002 2/20 0.50
SLC1A2 P43004 1/20 0.47
SLC1A1 P43005 1/20 0.47
CA2 P00918 2/20 0.47
MAPK1 P28482 1/20 0.47
GPR84 Q9NQS5 7/20 0.46
FFAR1 O14842 1/20 0.46
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
GAA P10253 1/20 0.45
MAPT P10636 1/20 0.44
LCK P06239 1/20 0.44
PPARD Q03181 1/20 0.44
ZDHHC20 Q5W0Z9 1/20 0.44
ZDHHC2 Q9UIJ5 1/20 0.44
HPGD P15428 1/20 0.42
RECQL P46063 1/20 0.42
HSD17B10 Q99714 1/20 0.42
ACE2 Q9BYF1 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6808464 1.00 GRIK1 (0.50) GRIK1GRIK2SLC1A2SLC1A1CA2
SCHEMBL27573982 1.00 GRIK1 (0.50) GRIK1GRIK2SLC1A2SLC1A1CA2
SCHEMBL7066300 1.00 GRIK1 (0.50) GRIK1GRIK2SLC1A2SLC1A1CA2
SCHEMBL6138155 1.00 GRIK1 (0.50) GRIK1GRIK2SLC1A2SLC1A1CA2
SCHEMBL7069281 1.00 GRIK1 (0.50) GRIK1GRIK2SLC1A2SLC1A1CA2
SCHEMBL7304504 1.00 GRIK1 (0.50) GRIK1GRIK2SLC1A2SLC1A1CA2
SCHEMBL8217023 1.00 GRIK1 (0.50) GRIK1GRIK2SLC1A2SLC1A1CA2
SCHEMBL7075183 1.00 GRIK1 (0.50) GRIK1GRIK2SLC1A2SLC1A1CA2
SCHEMBL8217020 1.00 GRIK1 (0.50) GRIK1GRIK2SLC1A2SLC1A1CA2
SCHEMBL7296146 1.00 GRIK1 (0.50) GRIK1GRIK2SLC1A2SLC1A1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6790834-B1 Cytostatic agents BRITISH BIOTECH PHARMACEUTICALS, LTD. (GB) 2004-09-14 US disclosed
EP-0925278-B1 CYTOSTATIC HYDROXAMIC ACID DERIVATIVES BRITISH BIOTECH PHARM (GB) 2002-07-17 EP disclosed
US-6169075-B1 ANTITUMOR AGENT INHIBITING THE PROLIFERATION OF A RANGE OF RAPIDLY DIVIDING TUMOUR CELLS LIKE MELANOMA AND/OR LYMPHOMA CELLS BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 2001-01-02 US disclosed
EP-0925278-A1 CYTOSTATIC HYDROXAMIC ACID DERIVATIVES BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 1999-06-30 EP disclosed
WO-1998011063-A1 CYTOSTATIC HYDROXAMIC ACID DERIVATIVES BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 1998-03-19 WO disclosed